Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro

Gemcitabine resistance is a common problem of pancreatic cancer chemotherapy, and how to reverse it plays an important role in the treatment of pancreatic cancer. This study investigated the effect of emodin on the gemcitabine-resistant pancreatic cancer cell line SW1990/Gem, and explored the potent...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, DIAN-LEI, BU, HEQI, LI, HONG, CHEN, HUI, GUO, HONG-CHUN, WANG, ZHAO-HONG, TONG, HONG-FEI, NI, ZHONG-LIN, LIU, HAI-BIN, LIN, SHENG-ZHANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584653/
https://www.ncbi.nlm.nih.gov/pubmed/22159556
http://dx.doi.org/10.3892/ijo.2011.1285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584653/
https://www.ncbi.nlm.nih.gov/pubmed/22159556
http://dx.doi.org/10.3892/ijo.2011.1285

Ejemplares similares